|
TOMM5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.442370E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.095800E-01 |
| Normal-vs-Stage2 |
4.280000E-01 |
| Normal-vs-Stage3 |
1.119840E-01 |
| Normal-vs-Stage4 |
1.052460E-02 |
| Stage1-vs-Stage2 |
5.489400E-01 |
| Stage1-vs-Stage3 |
1.543610E-01 |
| Stage1-vs-Stage4 |
2.196000E-03 |
| Stage2-vs-Stage3 |
4.906800E-01 |
| Stage2-vs-Stage4 |
3.286400E-02 |
| Stage3-vs-Stage4 |
1.819380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.813500E-02 |
| Normal-vs-AfricanAmerican |
4.911800E-01 |
| Normal-vs-Asian |
7.689200E-01 |
| Caucasian-vs-AfricanAmerican |
5.939000E-01 |
| Caucasian-vs-Asian |
9.662400E-01 |
| AfricanAmerican-vs-Asian |
8.849800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.490620E-01 |
| Normal-vs-Female |
3.711400E-01 |
| Male-vs-Female |
8.354800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.250300E-02 |
| Normal-vs-Extreme_Weight |
9.441700E-02 |
| Normal-vs-Obese |
6.408400E-01 |
| Normal-vs-Extreme_Obese |
7.560000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.765600E-01 |
| Normal_Weight-vs-Obese |
1.541220E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.817000E-01 |
| Extreme_Weight-vs-Obese |
4.653200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.561600E-01 |
| Obese-vs-Extreme_Obese |
9.912600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.344400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.094180E-01 |
| Normal-vs-Age(61-80Yrs) |
4.378800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.483600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.529400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.611800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.099400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.788600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.423000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.471200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.661970E-01 |
| Normal-VS-Type2 PRCC |
6.976200E-02 |
| Normal-VS-KIRP CIMP |
1.025160E-01 |
| Normal-VS-Unclassified PRCC |
1.069980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.443400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.621990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.154500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.581650E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.362500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.790100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.281640E-01 |
| Normal-vs-N1 |
7.875600E-02 |
| Normal-vs-N2 |
6.776200E-01 |
| N0-vs-N1 |
4.162200E-01 |
| N0-vs-N2 |
9.015800E-01 |
| N1-vs-N2 |
8.192800E-01 |
|
|
